Martuza Sarwar

Umea, AC, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer.

PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer.

Journal: Frontiers in cell and developmental biology

Published: October 20, 2021

FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.

FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.

Journal: Molecular oncology

Published: July 07, 2021

Establishment of Prostate Tumor Growth and Metastasis Is Supported by Bone Marrow Cells and Is Mediated by PIP5K1α Lipid Kinase.

Establishment of Prostate Tumor Growth and Metastasis Is Supported by Bone Marrow Cells and Is Mediated by PIP5K1α Lipid Kinase.

Journal: Cancers

Published: July 30, 2020

The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer.

The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer.

Journal: International journal of cancer

Published: February 20, 2019

The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.

The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.

Journal: Molecular medicine (Cambridge, Mass.)

Published: May 23, 2018

The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor.

The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor.

Journal: Oncogene

Published: December 18, 2017

Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells.

Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells.

Journal: Oncotarget

Published: July 28, 2016

The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.

The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 30, 2014

CDK1 interacts with RARγ and plays an important role in treatment response of acute myeloid leukemia.

CDK1 interacts with RARγ and plays an important role in treatment response of acute myeloid leukemia.

Journal: Cell cycle (Georgetown, Tex.)

Published: March 23, 2013

Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.

Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.

Journal: Urologic oncology

Published: October 14, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026